Search | Page 13 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

    ... Thiotepa 5 mg/kg/day x 2 or 10 mg/kg/day x 1 Drug: Cyclophosphamide 60 mg/ kg/day x 2 (or fludarabine 25mg/m2 x 5 if cyclophosphamide is contraindicated). Drug: Busulfan 0.8 mg/kg every ...

    Clinical Trial last updated 04/29/2016 - 3:18pm.

  2. Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

    ... infusion over 30 minutes, daily On days -6, -5, -4, and -3 Cyclophosphamide:1200 mg/m2 per day IV infusion over 2 hours on Days 6, -5, -4, ... day continuous IV infusion over 24 hours daily on days 1-4 Cyclophosphamide: 750 mg/m2 IV infusion over 30 minutes on day 5 Prednisone:60 ...

    Clinical Trial last updated 04/29/2016 - 1:00pm.

  3. Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia

    ... Intervention:  Drug: Cyclophosphamide,Campath IH and TBI DAY 5 TREATMENT 6 5 CYTOXAN 50 ...

    Clinical Trial last updated 04/26/2016 - 10:05am.

  4. Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia

    ... Associated Drug(s):  Cyclophosphamide Fludarabine Mycophenolate ... Fludarabine 30 mg/M2 IV on days -6 to -2 Drug: Cyclophosphamide 14.5 mg/kg IV on days -6, -5, 3, 4 Other Name: CTX ...

    Clinical Trial last updated 04/21/2016 - 1:19pm.

  5. Drugs

    ... N eoral, S andimmune cyclophosphamide C ytoxan ...

    Page last updated 03/02/2016 - 9:11am.

  6. "Moderate" dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution.

    ... line therapy of aplastic anemia with high dose cyclophosphamide causes toxicity and increased short-term mortality. We investigated cyclophosphamide at a lower "moderate" dose, in combination with aggressive ...

    Research Article last updated 10/07/2014 - 8:33am.

  7. Clinical Trials Report for January 2016

    ... malignancies. Giving low doses of chemotherapy, such as cyclophosphamide and fludarabine phosphate, before a donor stem ...

    Page last updated 01/07/2016 - 10:57am.

  8. Clinical Trials Report for December 2015

    ... malignancies. Giving low doses of chemotherapy, such as cyclophosphamide and fludarabine phosphate, before a donor stem ...

    Page last updated 11/30/2015 - 10:31am.

  9. Clinical Trials Report for September 2015

    ... non-myeloablative conditioning and post transplantation cyclophosphamide with partially HLA -mismatched donors. This ...

    Page last updated 08/26/2015 - 1:05pm.

  10. Clinical Trials Report for August 2015

    ... non-myeloablative conditioning and post transplantation cyclophosphamide with partially HLA -mismatched donors. This ...

    Page last updated 07/30/2015 - 8:45am.